Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study

Melissa L. Johnson, Zanete Zvirbule, К. К. Лактионов, Åslaug Helland, Byoung Chul Cho, Vanesa Gutiérrez, Benoît Colinet, H. Léna, M. Wolf, Maya Gottfried, Isamu Okamoto, Cor van der Leest, Patricia Rich, Jen‐Yu Hung, Christina Appenzeller, Zhaowen Sun, David Maag, Yan Luo, Caroline Nickner, Alena Vajikova, Philip Komarnitsky, Jair Bar